z-logo
open-access-imgOpen Access
Phorbol Ester Synergistically Increases Interferon-γ-lnduced Nitric Oxide Synthesis in Murine Microglial Cells
Author(s) -
Hyun-Ju Yoon,
ChangDuk Jun,
JongMoon Kim,
Gyoo-Nam Rim,
Hyung-Min Kim,
HunTaeg Chung
Publication year - 1994
Publication title -
neuroimmunomodulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.635
H-Index - 65
eISSN - 1423-0216
pISSN - 1021-7401
DOI - 10.1159/000097191
Subject(s) - protein kinase c , nitric oxide , staurosporine , arginase , nitric oxide synthase , activator (genetics) , phorbol , microbiology and biotechnology , chemistry , tetradecanoylphorbol acetate , cell culture , arginine , biology , biochemistry , endocrinology , kinase , receptor , amino acid , genetics
The effect of phorbol ester on the synthesis of nitric oxide (NO) in murine microglial cells was examined. Phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, alone had no effect, whereas PMA with recombinant interferon (rIFN)-gamma synergistically increased NO synthesis in murine microglial cells. The maximal effect of PMA on NO synthesis increase always fitted with the range for full activation of PKC in these cells. The increase of NO synthesis was reflected as increased amount of immunologic NO synthase (iNOS) mRNA detected by Northern blotting. Treatment with PKC inhibitors such as staurosporine or polymyxin B decreased rIFN-gamma-plus-PMA-stimulated NO synthesis. Further, prolonged incubation of the cells with PMA, which down-regulates PKC activity, abolished the synergistic cooperative effect with IFN-gamma. NG-monomethyl-L-arginine monohydrate, an analogue of L-arginine, and arginase inhibited rIFN-gamma-plus-PMA-induced NO production in murine microglial cells. On the basis of these observations, we conclude that PKC might not be involved in the expression of iNOS, but instead, might be involved in the posttranscriptional modification of iNOS mRNA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here